New European UTI Guidelines Say Skip the Antibiotics for Asymptomatic Bacteriuria

The European Association of Urology (EAU) has released its 2026 Urological Infections Guidelines, introducing a new classification system for UTIs and reinforcing a message that may surprise many patients: bacteria in the urine without symptoms usually shouldn't be treated with antibiotics — even for women prone to recurrent UTIs.

In this article:

• What changed in the classification system
• Why asymptomatic bacteriuria shouldn't be treated
• When delaying antibiotics may make sense
• Why this matters for chronic UTI patients

What Changed in the Classification System

The EAU guidelines replace the traditional "complicated" versus "uncomplicated" UTI labels with a framework based on clinical presentation: localized infections, such as cystitis, versus systemic infections, such as pyelonephritis. The 2026 update also adds new chapters on fungal UTIs and herpes simplex virus, and revises evidence around antibiotic prophylaxis before prostate biopsy.

Why Asymptomatic Bacteriuria Shouldn't Be Treated

Asymptomatic bacteriuria — bacterial growth in urine without any symptoms — occurs in roughly 1% to 5% of healthy premenopausal women, and more often in older or institutionalized populations. José Medina-Polo, MD, a member of the EAU guidelines panel, said the central message is to avoid antibiotic treatment for this condition in most cases. The guidelines note that antibiotic treatment for asymptomatic bacteriuria actually increases recurrence risk in women prone to UTIs, rather than preventing future infections.

The recommendation against screening and treatment applies broadly: women without risk factors, well-controlled diabetics, postmenopausal women, and people with recurrent UTIs. The main exceptions remain pregnant women and patients about to undergo urologic procedures that could disrupt the urinary tract lining.

When Delaying Antibiotics May Make Sense

Medina-Polo also pointed to a more nuanced shift: for patients with mild, localized symptoms and no complicating risk factors, delaying antibiotic treatment altogether may be appropriate after proper counseling, since a majority of mild localized infections can resolve without intervention.

Why This Matters

For women managing chronic or recurrent UTIs, this reinforces a theme also showing up in the AUA's own updated guidance: more testing and more antibiotics aren't automatically better care. Overtreating asymptomatic bacteriuria can disrupt protective bacterial colonization and contribute to antibiotic resistance — a real concern for patients who already cycle through frequent antibiotic courses. If your provider recommends against treating a positive urine culture that isn't accompanied by symptoms, this guidance is part of the reasoning why.

Conclusion

The EAU guidelines are a European framework, but they reflect a broader international shift in urology — one already echoed in recent U.S. guideline updates — toward more selective, symptom-driven antibiotic use rather than reflexive treatment of any positive test result.

Sources

• Medscape, "Urologic Infections: European Association of Urology 2026 Guideline Updates" (August 2026): medscape.com
• Uroweb, "EAU Guidelines on Urological Infections" (2026): uroweb.org